Article ; Online: Network pharmacology-based mechanism prediction and pharmacological validation of Bushenhuoxue formula attenuating postmenopausal osteoporosis in ovariectomized mice.
Journal of orthopaedic surgery and research
2023 Volume 18, Issue 1, Page(s) 200
Abstract: Background: Bushenhuoxue (BSHX) formula, a ten-compound herbal decoction, is widely used to treat postmenopausal osteoporosis (PMOP) in China. However, the mechanism is not clear yet.: Methods: The underlying biological processes and signaling ... ...
Abstract | Background: Bushenhuoxue (BSHX) formula, a ten-compound herbal decoction, is widely used to treat postmenopausal osteoporosis (PMOP) in China. However, the mechanism is not clear yet. Methods: The underlying biological processes and signaling pathways were predicted by network pharmacology. In vivo experimental study, 24 female C57BL/6 J mice were randomly divided into sham, ovariectomized (OVX) and BSHX formula groups. Mice in the latter two groups were subjected to bilateral ovariectomy, and mice in the BSHX formula group were extra treated by BSHX formula at an oral dosage of 0.2 mL/10 g for 8 weeks. The femur samples were harvested for tissue analyses including μCT assay, histology and immunohistochemical (IHC) staining of VEGF signaling. Results: A total of 218 active ingredients and 274 related targets were identified in BSHX formula. After matching with 292 targets of PMOP, 64 overlapping genes were obtained. GO and KEGG enrichment analyses on these 64 genes revealed that angiogenesis and VEGF signaling were considered as the potential therapeutic mechanism of BSHX formula against PMOP. Animal experiments showed that mice in the BSHX formula-treated group presented increased bone mass, microstructural parameters, blood vessel numbers and an activation of VEGF signaling (VEGF, COX2, eNOS and CD31) compared to the OVX mice. Conclusion: This study revealed that BSHX formula exerts anti-PMOP effects possibly through activating VEGF signaling-mediated angiogenesis. |
---|---|
MeSH term(s) | Humans ; Mice ; Female ; Animals ; Osteoporosis, Postmenopausal/drug therapy ; Osteoporosis, Postmenopausal/metabolism ; Vascular Endothelial Growth Factor A ; Network Pharmacology ; Mice, Inbred C57BL ; Signal Transduction ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Ovariectomy |
Chemical Substances | Vascular Endothelial Growth Factor A ; Drugs, Chinese Herbal |
Language | English |
Publishing date | 2023-03-14 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2252548-8 |
ISSN | 1749-799X ; 1749-799X |
ISSN (online) | 1749-799X |
ISSN | 1749-799X |
DOI | 10.1186/s13018-023-03696-7 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.